# A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant

> **NCT05675930** · PHASE2 · RECRUITING · sponsor: **Memorial Sloan Kettering Cancer Center** · enrollment: 44 (estimated)

## Conditions studied

- Graft-Versus-Host Disease
- GVHD
- Undefined

## Interventions

- **DEVICE:** Photobiomodulation Therapy
- **OTHER:** Placebo sham device

## Key facts

- **NCT ID:** NCT05675930
- **Lead sponsor:** Memorial Sloan Kettering Cancer Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2022-12-22
- **Primary completion:** 2026-12-22
- **Final completion:** 2026-12-22
- **Target enrollment:** 44 (ESTIMATED)
- **Last updated:** 2026-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05675930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05675930, "A Study of Photobiomodulation (PBM) Therapy in People With Oral Graft-Versus-Host Disease (GVHD) After Stem Cell Transplant". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05675930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*